14/09/2009

Are the Endocrine Society’s Clinical Practice Guidelines on androgen therapy in women misguided? A Commentary


Traish A. Guay A.T. Spark R.F. and the Testosterone Therapy in Women Study Group (including Graziottin A.)
Are the Endocrine Society’s Clinical Practice Guidelines on androgen therapy in women misguided? A Commentary
J. Sex. Med. 2007; 4: 1223–1235

CONDIVIDI SU

The Endocrine Society Clinical Guidelines on Androgen Therapy in Women do not necessarily represent the opinion held by the many health-care professionals and clinicians who are specialized in the evaluation, diagnosis, and treatment of women’s health in androgen insufficiency states. The recommendations provided in the published Guidelines are neither accurate nor complete. We disagree with the therapeutic nihilism promoted by these Guidelines. The members of the Guidelines Panel, in their own disclaimer, stated that the Guidelines do not establish a standard of care.
Based on data available in the contemporary literature, on the role of androgens in women’s health, we provide in this commentary a point-by-point discussion of the arguments made by the Panel in arriving at their recommendations. It is our view that the Guidelines are not based on the preponderance of scientific evidence.

top


Available documents:
Full text of the article


By courtesy of Blackwell Publishing

FAIR USE: The content of this paper can be downloaded, printed and read for strictly personal and non-profit use. Any citation for didactic and/or scientific purpose must quote the title of the document, the name of the author(s), the data of the book or journal, and the URL of the site (www.alessandragraziottin.it).

WARNING: Every therapy must be discussed, tailored, prescribed and monitored by the M.D. personally consulted. Every information presented in this website can not surrogate the personal relationship with the caring physician nor be utilized without specific medical advice.